Literature DB >> 4738511

[Studies on the components of Magnolia obovata Thunb. 3. Occurrence of magnolol and hõnokiol in M. obovata and other allied plants].

M Fujita, H Itokawa, Y Sashida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4738511     DOI： 10.1248/yakushi1947.93.4_429

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN： 0031-6903            Impact factor:   0.302


× No keyword cloud information.
  21 in total

1.  Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.

Authors:  Zhiyun He; Dharmalingam Subramaniam; Satish Ramalingam; Animesh Dhar; Russell G Postier; Shahid Umar; Youcheng Zhang; Shrikant Anant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells.

Authors:  Sivapriya Ponnurangam; Joshua M V Mammen; Satish Ramalingam; Zhiyun He; Youcheng Zhang; Shahid Umar; Dharmalingam Subramaniam; Shrikant Anant
Journal:  Mol Cancer Ther       Date:  2012-02-08       Impact factor: 6.261

3.  Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.

Authors:  Shinichi Harada; Maya Kishimoto; Mana Kobayashi; Kazuo Nakamoto; Wakako Fujita-Hamabe; Hwei-Hsien Chen; Ming-Huan Chan; Shogo Tokuyama
Journal:  J Nat Med       Date:  2012-01-20       Impact factor: 2.343

4.  Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients.

Authors:  Minpei Kuroda; Yoshihiro Mimaki; Takayuki Ohtomo; Junji Yamada; Tozo Nishiyama; Tatsumasa Mae; Hideyuki Kishida; Teruo Kawada
Journal:  J Nat Med       Date:  2011-10-11       Impact factor: 2.343

5.  Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.

Authors:  Dimiter B Avtanski; Arumugam Nagalingam; Michael Y Bonner; Jack L Arbiser; Neeraj K Saxena; Dipali Sharma
Journal:  Mol Oncol       Date:  2014-01-15       Impact factor: 6.603

6.  Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect.

Authors:  Xiaodong Tan; Yingjie Zhou; Aditi Agarwal; Michelle Lim; Yingyue Xu; Yueming Zhu; Joseph O'Brien; Elizabeth Tran; Jing Zheng; David Gius; Claus-Peter Richter
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

7.  Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.

Authors:  Gaurav Kaushik; Deep Kwatra; Dharmalingam Subramaniam; Roy A Jensen; Shrikant Anant; Joshua M V Mammen
Journal:  Am J Surg       Date:  2014-10-02       Impact factor: 2.565

8.  Honokiol inhibits melanoma stem cells by targeting notch signaling.

Authors:  Gaurav Kaushik; Anand Venugopal; Prabhu Ramamoorthy; David Standing; Dharmalingam Subramaniam; Shahid Umar; Roy A Jensen; Shrikant Anant; Joshua M V Mammen
Journal:  Mol Carcinog       Date:  2014-12-09       Impact factor: 4.784

9.  The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus.

Authors:  Yu-Cheng Lu; Hwei-Hsien Chen; Chien-Hsin Ko; Yi-Ruu Lin; Ming-Huan Chan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-18       Impact factor: 3.000

10.  Antinociceptive actions of honokiol and magnolol on glutamatergic and inflammatory pain.

Authors:  Yi-Ruu Lin; Hwei-Hsien Chen; Yu-Chin Lin; Chien-Hsin Ko; Ming-Huan Chan
Journal:  J Biomed Sci       Date:  2009-10-16       Impact factor: 8.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.